Lexology October 24, 2024
Cozen O'Connor

  • New Jersey AG Matthew Platkin announced the adoption of new rules designed to promote greater transparency in prescription drug pricing.
  • The new rules implement recently enacted legislation intended to control prescription costs by imposing registration, reporting, and compliance requirements on manufacturers, insurance carriers, wholesalers, and other entities, who will be required to provide the AG’s office with information about drugs with significant price increases or high launch prices.
  • The AG’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Pharma, Pharma / Biotech, States
Related Articles:
5 objectives for achieving high-quality primary care at the state level
State Reported Efforts to Address Health Disparities: A 50 State Review
How much each state has spent to expand Medicaid
Cardiologists per capita in the worst states for healthcare
The largest Medicare Advantage insurer by state

Share This Article